Compare Cronos Group Inc (CRON) vs Under Armour Inc Class A (UAA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Under Armour Inc Class A — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.20B), while Under Armour Inc Class A trades at $4.89 (market cap $2.05B). The key difference: Under Armour Inc Class A is the larger of the two by market cap, and Cronos Group Inc is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Under Armour Inc Class A for 99 Days on average.
| CRON | UAA | |
|---|---|---|
Market Cap | $1.20B | $2.05B |
Volume | 450,387 | 13,461,776 |
Sector | Health | Consumer Cyclical |
52-Week High | $3.55 | $8.14 |
52-Week Low | $2.30 | $4.17 |
Typical Hold Time | 22 Days | 99 Days |
Enterprise Value | $401.73M | $3.03B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
Under Armour (UAA) trades at $4.82, down 1.23% amid ongoing revenue challenges despite recent earnings beats. The stock shows a bullish technical signal with mixed oscillators, while fundamentals reveal negative profitability metrics including -9.99% net income margin and -29.82% ROE. Recent news highlights the company's brand transformation efforts and international market resilience as it navigates softer North American demand.
The outlook remains cautious with analyst consensus at $5.79 target (20% upside) but 57% hold ratings. Key risks include persistent revenue declines, negative cash flow trends, and competitive pressures. Investment opportunity exists if margin improvements and international growth can offset domestic weakness, but execution risks remain elevated.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Under Armour Inc Class A
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.
Read more on UAA →
